Web notes  

September 2016
PUBLICATIONS - Back

Dermatology Archives

1. Kim JE, Patel MA, Mangraviti A, Kim ES, Theodros D, Velarde E, Liu A, Sankey E, Tam A, Xu H, Mathios D, Jackson CM, Harris-Bookman S, Garzon-Muvdi T, Sheu M, Martin AM, Tyler BM, Tran PT, Ye X, Olivi A, Taube JM, Burger PC, Drake CG, Brem H, Pardoll D, and Lim M. Combination therapy with anti-PD-1, anti-TIM-3, and focal radiation results in regression of murine gliomas. Clin Can Res. 2016 Jun 29 [Epub ahead of print].
Key words: PD-1, TIM-3, focal radiation, murine gliomas
http://www.ncbi.nlm.nih.gov/pubmed/27358487

2. Voltaggio L, Cimino-Mathews A, Bishop JA, Argani P, Cuda JD, Epstein JI, Hruban RH, Netto GJ, Stoler MH, Taube JM, Vang R, Westra WH, Montgomery EA. Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ system. CA Cancer J Clin. 2016 Jun 6. [Epub ahead of print]
Key words: carcinoma in situ; dysplasia; intraepithelial neoplasia; precancer; preinvasive neoplasia
http://www.ncbi.nlm.nih.gov/pubmed/27270763

1. Topalian SL, Taube JM, Anders RA, Pardoll DM. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. Nat Rev Cancer. 2016 May;16(5):275-87.
Key words: biomarkers, cancer therapy
http://www.ncbi.nlm.nih.gov/pubmed/?term=27079802

1. Haskin A, Aguh C. All hairstyles are not created equal: What the dermatologist needs to know about black hairstyling practices and the risk of traction alopecia (TA). J Am Acad Dermatol. 2016 Apr 21. pii: S0190-9622(16)01398-0. doi: 10.1016/j.jaad.2016.02.1162.
Key words: alopecia; ethnic hair; ethnic skin; hair loss; nonscarring alopecia; traction alopecia
https://www.ncbi.nlm.nih.gov/pubmed/?term=27114262

2. Haskin A, Kim N, Aguh C. A new drug with a nasty bite: A case of krokodil-induced skin necrosis in an intravenous drug user. JAAD Case Reports 2.2 (2016): 174-176.
Key words: desomorphine , intravenous drug abuse , krokodil, substance abuse, ulceration, wound healing
http://www.sciencedirect.com/science/article/pii/S2352512616000230
PMID: 27222881

3. Kim D, Hossain MZ, Nieves A, Gu L, Ratliff TS, Mi Oh S, Park A, Han S, Yang NB, Qi J, Taube JM, Kang S, Garza LA. To control site-specific skin gene expression, autocrine mimics paracrine canonical Wnt signaling and is activated ectopically in skin disease. Am J Pathol. 2016 May;186(5):1140-50. doi: 10.1016/j.ajpath.2015.12.030.
Key words: gene expression, autocrine, paracrine, skin disease
https://www.ncbi.nlm.nih.gov/pubmed/?term=27105735

4. Nghiem P, Bhatia S, Lipson EJ, Kudchadkar R, Miller N, Annamalai L, Berry S, Daud A, Fling S, Friedlander P, Kluger H, Kohrt H, Lundgren L, Margolin K, Mitchell A, Olencki T, Reddy S, Shantha E, Sharfman WH, Sharon E, Shemanski L, Shinohara M, Sunshine J, Taube JM, Thompson J, Yearley J, Topalian SL, Cheever M. PD-1 blockade with pembrolizumab in advanced Merkel cell carcinoma. New Engl J Med. Apr 19 [Epub ahead of print].
Key words: PD-1, pembrolizumab, Merkel cell carcinoma
https://www.ncbi.nlm.nih.gov/pubmed/?term=27093365

5. Topalian SL, Taube JM, Anders RA, Pardoll DM. Mechanism-based biomarkers for cancer therapy with immune checkpoint blockade. Nat Rev Cancer. 2016 May;16(5):275-87. doi: 10.1038/nrc.2016.36. Epub 2016 Apr 15.
Key words: biomarkers, cancer therapy, immune checkpoint blockade
https://www.ncbi.nlm.nih.gov/pubmed/?term=27079802

1. Moulla AA, Magdy N, Francis N, Taube J, Ronnett BM, El-Bahrawy M. Rare skin adnexal and melanocytic tumors arising in ovarian mature cystic teratomas: a report of 3 cases and review of the literature. Int J Gynecol Pathol. 2016 Mar 11. [Epub ahead of print]
Key words: adnexal tumor, melanocytic tumor, cystic teratoma
http://www.ncbi.nlm.nih.gov/pubmed/?term=26974995

2. Lipson EJ, Bagnasco SM, Moore J, Jang S, Patel M, Zachary AA, Taube JM, Drake CG. Tumor regression and allograft rejection after administration of PD-1 antibody to a kidney transplant recipient with metastatic cutaneous squamous cell carcinoma. New Engl J Med. 2016;374:896-8.
Key words: tumor regression, allograft, PD-1, kidney transplant, cutaneous squamous cell carcinoma
http://www.ncbi.nlm.nih.gov/pubmed/26962927

1. He A, Kwatra SG, Kim N, Braunstein I. Bier Spots: a benign vascular anomaly. BMJ Case Rep. 2016 Feb 24 2016: pii: bcr2016214761. doi: 10.1136/bcr-2016-214761.
http://www.ncbi.nlm.nih.gov/pubmed/?term=26912771

2. Thompson E, Taube JM, Elwood H, Sharma R, Meeker A, Warzecha HN, Argani P, Cimino-Mathews A, Emens LA. The immune microenvironment of breast ductal carcinoma in situ. Mod Pathol. 2016 Mar;29(3):249-58.
http://www.ncbi.nlm.nih.gov/pubmed/?term=26769139

3. Thompson ED, Zahurak M, Murphy A, Cornish T, Cuka N, Abdelfatah E, Yang S, Duncan M, Ahuja N, Taube JM, Anders RA, Kelly RJ. Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma. Gut. 2016 Jan 22. pii: gutjnl-2015-310839.
Key words: cancer immunobiology; gastric cancer; immune response; immunotherapy
http://www.ncbi.nlm.nih.gov/pubmed/?term=26801886%5Buid%5D

4. Nelson AM, Katseff AS, Resnik SR, Ratliff TS, Zhu AS, Garza LA. Interleukin 6 null mice paradoxically display increased Stat3 activity and wound-induced hair neogenesis. J Invest Dermatol. 2016. Epub 2016/02/02. doi: 10.1016/j.jid.2015.12.043.
Key words: interleukin-6, Stat3 activity, hair neogenesis
http://www.ncbi.nlm.nih.gov/pubmed/?term=26829029

1. Cimino-Mathews A, Thompson E, Taube J, Elwood H, Sharma R, Meeker A, Warzecha H, Argani P, Emens L. The immune microenvironment of breast ductal carcinoma in situ. Mod Pathol. 2016. Jan 15. [Epub ahead of print].
Key words: breast ductal carcinoma in situ, tumor infiltrating lymphocytes, programmed death ligand 1 (PD-L1), estrogen, progesterone
http://www.ncbi.nlm.nih.gov/pubmed/?term=26769139

2. Decker, CG, Wang, Y, Paluck, SJ, Shen, L, Loo, JA, Levine, AJ, Miller, LS, Maynard, HD. Fibroblast growth Factor 2 dimer with superagonist in vitro activity improves granulation tissue formation during wound healing. Biomaterials. 2016 March; 81: 157-168.
Key words: angiogenesis; diabetic wounds; dimerization; growth factor; pegylation; wound healing
http://www.ncbi.nlm.nih.gov/pubmed/?term=26731578

3. Hinds G, Newsome A, McKay S, Harvey V. Health disparities in mycosis fungoides. Cogent Medicine. Published online 28 Jan 2016.
Key words: mycosis fungoides
http://cogentoa.tandfonline.com/doi/abs/10.1080/2331205X.2015.1134041

4. Thompson ED, Zahurak M, Murphy A, Cornish T, Cuka N, Abdelfatah E, Yang S, Duncan M, Ahuja N, Taube JM, Anders RA, Kelly RJ. Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma. Gut. 2016 Jan 22. pii: gutjnl-2015-310839.
Key words: cancer immunobiology; gastric cancer; immune response; immunotherapy
http://www.ncbi.nlm.nih.gov/pubmed/?term=26801886


1. Cimino-Mathews A, Thompson E, Taube JM, Ye X, Lu Y, Meeker A, Xu H, Sharma R, Lecksell K, Cornish TC, Cuka N, Argani P, Emens LA. PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas. Hum Pathol. 2016 Jan;47(1):52-63.
Key words: Metastatic breast cancer; PD-L1; Primary breast cancer; Tumor infiltrating lymphocytes; Tumor microenvironment
http://www.ncbi.nlm.nih.gov/pubmed/?term=26527522

2. Ascierto PA, Atkins M, Bifulco C, Botti G, Cochran A, Davies M, Demaria S, Dummer R, Ferrone S, Formenti S, Gajewski TF, Garbe C, Khleif S, Kiessling R, Lo R, Lorigan P, Arthur GM, Masucci G, Melero I, Mihm M, Palmieri G, Parmiani G, Puzanov I, Romero P, Schilling B, Seliger B, Stroncek D, Taube J, Tomei S, Zarour HM, Testori A, Wang E, Galon J, Ciliberto G, Mozzillo N, Marincola FM, Thurin M. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014. J Transl Med. 2015 Nov 30;13:374.
Key words: melanoma, research
http://www.ncbi.nlm.nih.gov/pubmed/?term=26619946

3. Lastwika KJ, Wilson W 3rd, Li QK, Norris J, Xu H, Ghazarian SR, Kitagawa H, Kawabata S, Taube JM, Yao S, Liu LN, Gills JJ, Dennis PA. Control of PD-L1 expression by oncogenic activation of the AKT/mTOR pathway in non-small cell lung cancer. Cancer Res. 2015 Dec 4. pii: canres.3362.2014. [Epub ahead of print]
Key words: PD-L1, non-small cell lung cancer
http://www.ncbi.nlm.nih.gov/pubmed/?term=26637667

4. Jefferson J, Taube J, Grossberg A. Follicular mucinosis in a male adolescent with a history of acute myelogenous leukemia and graft-versus-host disease. Pediatr Dermatol. 2016 Jan;33(1):e34-5.
Key words: graft-versus-host disease, follicular mucinosis, acute myelogenous leukemia
http://www.ncbi.nlm.nih.gov/pubmed/?term=26645410

1. Chan, LC, Chaili, S, Filler, SG, Barr, K, Wang, H, Kupferwasser, D, Edwards, JE, Xiong, YQ, Ibrahim, AS, Miller, LS, Schmidt, CS, Hennessey, JS, Yeaman, MR. 2015. Non-redundant roles of IL-17A and IL-22 in murine host defense against cutaneous and hematogenous infection due to methicillin-resistant Staphylococcus aureus. Infection and Immunity. Nov. 83(11):4427-37.
Key words: MRSA, Staphylococcus aureus, IL-7A, IL-22, infection
http://www.ncbi.nlm.nih.gov/pubmed/?term=26351278

2. Jackson CM, Kochel CM, Nirschl CJ, Durham NM, Ruzevick J, Alme A, Francica BJ, Elias J, Daniels A, Dubensky TW Jr, Lauer P, Brockstedt D, Baxi EG, Calabresi PA, Taube JM, Pardo CA, Brem H, Pardoll DM, Lim M, Drake CG. Systemic tolerance mediated by melanoma brain tumors is reversible by radiotherapy and vaccination. Clin Cancer Res. 2015 Oct 21. pii: clincanres.1516.2015.
Key words: melanoma, brain tumor, radiotherapy
http://www.ncbi.nlm.nih.gov/pubmed/?term=26490306

1. Cimino-Mathews A, Thompson E. Taube JM, Ye X, Lu Y, Meeker A, Xu H, Sharma R, Lecksell K, Cornish TC, Cuka N, Argani P, Emens LA. PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas. Hum Pathol. 2015 Sept 24 [Epub ahead of print].
Key words: PD-L1, breast carcinoma, metastases
http://www.ncbi.nlm.nih.gov/pubmed/26527522

2. Jackson C, Kochel C, Nirschl C, Durham N, Ruzevick J, Alme A, Francica B, Elias J, Daniels A, Dubensky T, Jr., Lauer P, Brockstedt D, Baxi E, Calabresi P, Taube J, Pardo C, Brem H, Pardoll D, Lim M, Drake C. Systemic tolerance mediated by CNS melanoma is reversible by combined radiotherapy and vaccination. Clin Can Res. 2015 Oct 21. [Epub ahead of print].
Key words: vaccination, CNS melanoma, radiotherapy
http://www.ncbi.nlm.nih.gov/pubmed/26490306

3. Opneja A, Mahajan S, Kapoor S, Marur S, Yang S, Manno R. Unusual paraneoplastic presentation of cholangiocarcinoma. Cas Rep Med. 2015;2015:806835 [Epub 2015 Oct 1].
Key words: paraneoplasm, cholangiocarcinoma
http://www.ncbi.nlm.nih.gov/pubmed/26495003

4. Ryatova MS, Okoye GA. Dermatology in the North American Indian/Alaska Native population. Int J Derm. 2015 Oct 16. doi: 10.1111/ijd.12977 [Epub ahead of print].
Key words: dermatology, North American Indian, Alaska
http://www.ncbi.nlm.nih.gov/pubmed/26474729

5. Vlassova N, Kuhn D, Okoye GA. Hidradenitis suppurativa disproportionatley affects African Americans: a single-center retrospective analysis. Acta Derm Venereol. 2015 Nov 4;95(8):990-991.
Key words: hidradenitis suppurativa, African Americans
http://www.ncbi.nlm.nih.gov/pubmed/26073615

6. Yang SH, Qi J, Esandrio J, Leung S, Taube JM, Garza LA, Allen R, Kang S, and Chien AL. Efficacy and tolerability of a novel biopsy device for removing benign epidermal skin lesions. Derm Surg. 2015 Nov;41(11):1264-73.
Key words: biopsy, skin lesions, benign
http://www.ncbi.nlm.nih.gov/pubmed/26506067

1. Chan, LC, Chaili, S, Filler, SG, Barr, K, Wang, H, Kupferwasser, D, Edwards, JE, Xiong, YQ, Ibrahim, AS, Miller, LS, Schmidt, CS, Hennessey, JS, Yeaman, MR. 2015. Non-redundant roles of IL-17A and IL-22 in murine host defense against cutaneous and hematogenous infection due to methicillin-resistant Staphylococcus aureus. Infection and Immunity. 2015 Nov;83(11):4427-37.
Key words: IL-7A, IL-22, murine host defense, S. aureus
http://www.ncbi.nlm.nih.gov/pubmed/?term=26351278

2. Opneja A, Mahajan S, Kapoor S, Marur S, Yang SH, Manno R. Unusual paraneoplastic presentation of cholangiocarcinoma. Case Reports in Medicine. 2015;2015:806835. doi: 10.1155/2015/806835.
Key words: paraneoplastic syndrome, cholangiocarcinoma
http://www.hindawi.com/journals/crim/2015/806835/
PMID:26495003

1. Hobbs RP, DePianto DJ, Jacob JT, Han MC, Chung BM, Batazzi AS, Poll BG, Guo Y, Han J, Ong S, Zheng W, Taube JM, ?iháková D, Wan F, Coulombe PA. Keratin-dependent regulation of Aire and gene expression in skin tumor keratinocytes. Nat Genet. 2015 Aug;47(8):933-8.
Key words: keratinocytes, keratin, autimmune regulator, gene expression
http://www.ncbi.nlm.nih.gov/pubmed/26168014

2. Rodi? N, Zampella J, Sharma R, Burns KH, Taube JM. Diagnostic utility of 5-hydroxymethylcytosine immunohistochemistry in melanocytic proliferations. J Cutan Pathol. 2015 Aug 4. doi: 10.1111/cup.12564.
Key words: 5-hydroxymethylcytosine; dermatopathology; epigenetics; melanoma; nevus
http://www.ncbi.nlm.nih.gov/pubmed/26239102

3. Sunshine J, Taube JM. PD-1/PD-L1 inhibitors. Curr Opin Pharmacol. 2015 Aug;23:32-8.
Key words: PD-1, PD-L1
http://www.ncbi.nlm.nih.gov/pubmed/26047524

4. Vlassova N, Kuhn D, Okoye GA. Hidradenitis Suppurativa disproportionately affects African Americans: a single-center retrospective analysis. Acta Derm Venereol. 2015 Jun 15.
Key words: Hidradenitis Suppurativa, African Americans
http://www.ncbi.nlm.nih.gov/pubmed/26073615

1. Hobbs RP, DePianto DJ, Jacob JT, Han MC, Chung BM, Batazzi AS, Poll BG, Guo Y, Han J, Ong S, Zheng W, Taube JM, ?iháková D, Wan F, Coulombe PA. Keratin-dependent regulation of Aire and gene expression in skin tumor keratinocytes. Nat Genet. 2015 Aug;47(8):933-8.
Key words: skin tumor, keratinocytes, gene expression
http://www.ncbi.nlm.nih.gov/pubmed/26168014

2. Lipson EJ, Sharfman WH, Chen S, McMiller TL, Pritchard TS, Salas JT, Sartorius-Mergenthaler S, Freed I, Ravi S, Wang H, Luber B, Sproul JD, Taube JM, Pardoll DM, Topalian SL. Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting. J Transl Med. 2015;13:214.
Key words: melanoma, GM-CSF, vaccine
http://www.ncbi.nlm.nih.gov/pubmed/26143264

3. Nelson A, Reddy S, Ratliff T, Hossain Z, Katseff A, Zhu A, Chang E, Resnik S, Page C, Kim D, Whittam A, Miller L, Garza A. dsRNA Released by tissue damage activates TLR3 to drive skin regeneration. Cell Stem Cell. 2015; 17(2): 139-151.
Key words: tissue damage, TLR3, skin regeneration
http://www.cell.com/cell-stem-cell/abstract/S1934-5909(15)00307-0
PMID: 26253200

4 Sunshine J, Taube JM. PD-1/PD-L1 inhibitors. Curr Opin Pharmacol. 2015;23:32-8.
Key words: PD-1, PD-L1, immunomodulation
http://www.ncbi.nlm.nih.gov/pubmed/26047524

1. Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, Biedrzycki B, Donehower RC, Zaheer A, Fisher GA, Crocenzi TS, Lee JJ, Duffy SM, Goldberg RM, de la Chapelle A, Koshiji M, Bhaijee F, Huebner T, Hruban RH, Wood LD, Cuka N, Pardoll DM, Papadopoulos N, Kinzler KW, Zhou S, Cornish TC, Taube JM, Anders RA, Eshleman JR, Vogelstein B, Diaz LA Jr. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015 Jun 25;372(26):2509-20.
Key words: PD-1, tumors
http://www.ncbi.nlm.nih.gov/pubmed/?term=26028255

2. Sunshine J, Taube JM. PD-1/PD-L1 inhibitors. Curr Opin Pharmacol. 2015 Jun 1;23:32-8.
Key words: PD-1 inhibitors, PD-L1 inhibitors
http://www.ncbi.nlm.nih.gov/pubmed/?term=26047524

1. Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, Biedrzycki B, Donehower RC, Zaheer A, Fisher GA, Crocenzi TS, Lee JJ, Duffy SM, Goldberg RM, de la Chapelle A, Koshiji M, Bhaijee F, Huebner T, Hruban RH, Wood LD, Cuka N, Pardoll DM, Papadopoulos N, Kinzler KW, Zhou S, Cornish TC, Taube JM, Anders RA, Eshleman JR, Vogelstein B, Diaz LA Jr. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015 Jun 25;372(26):2509-20.
Key words: somatic mutations; mismatch-repair defects; PD-1; immune checkpoint blockade
http://www.ncbi.nlm.nih.gov/pubmed/26028255

2. Taube JM, Young GD, McMiller TL, Chen S, Salas JT, Pritchard TS, Xu H, Meeker AK, Fan J, Cheadle C, Berger AE, Pardoll DM, Topalian SL. Differential expression of immune-regulatory genes associated with PD-L1 display in melanoma: implications for PD-1 pathway blockade. Clin Cancer Res. 2015 May 5. pii: clincanres.0244.2015. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/25944800

1. Faraj SF, Munari E, Guner G, Taube J, Anders R, Hicks J, Meeker A, Schoenberg M, Bivalacqua T, Drake C, Netto GJ. Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinoma. Urology. 2015 Mar;85(3):703.e1-6.
Key words: urothelial carcinoma, PD-L1 expression, T cells, CD8+
http://www.ncbi.nlm.nih.gov/pubmed/?term=25733301

2. Miller, LS. Adipocytes armed against Staphylococcus aureus. New Engl J Med. 2015;372(14):1368-1370.
Key words: adipocytes, S. auereus
http://www.nejm.org/doi/full/10.1056/NEJMcibr1500271
PMID: 2583042

1. Püttgen KB. Evidence and nuances of propranolol safety. Br J Dermatol. 2015 Feb;172(2):319-20. doi: 10.1111/bjd.13600.
Key words: propranolol, safety, hemangioma, pediatrics

http://www.ncbi.nlm.nih.gov/pubmed/?term=25660680

1. Mitkov M, Balagula Y, Taube JM, Lockshin B. Plaque-like syringoma with involvement of deep reticular dermis. J Am Acad Dermatol. 2014 Nov;71(5):e206-7.
Key words: plaque, syringoma, reticular dermis
http://www.ncbi.nlm.nih.gov/pubmed/25437993

2. Rodic N, Anders RA, Eshleman JR, Lin MT, Xu H, Kim JH, Beierl K, Chen S, Luber BS, Wang H, Topalian SL, Pardoll DM, Taube JM. PD-L1 expression in melanocytic lesions does not correlate with the BRAF V600E mutation. Cancer Immunol Res. 2014 Nov 4. pii: canimm.0145.2014. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/25370533

3. Llosa NJ, Cruise M, Tam A, Wick EC, Hechenbleikner EM, Taube JM, Blosser L, Fan H, Wang H, Luber B, Zhang M, Papadopoulos N, Kinzler KW, Vogelstein B, Sears CL, Anders RA, Pardoll DM, Housseau F. The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. Cancer Discov. 2014 Oct 30. pii: CD-14-0863. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/25358689

4. Crane GM, Xian RR, Burns KH, Borowitz MJ, Duffield AS, Taube JM. Primary effusion lymphoma presenting as a cutaneous intravascular lymphoma. J Cutan Pathol. 2014 Oct 30. doi: 10.1111/cup.12405. [Epub ahead of print].
http://www.ncbi.nlm.nih.gov/pubmed/25355615

5. Mathios D, Ruzevick J, Jackson CM, Xu H, Shah S, Taube JM, Burger PC, McCarthy EF, Quinones-Hinojosa A, Pardoll DM, Lim M. PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment. J Neurooncol. 2014 Oct 28. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/25349132

1. Bernthal, NM, Taylor, BN, Meganck, JA, Wang, Y, Shahbazian, JH, Niska, JA, Francis, KP, Miller, LS. 2014. Combined in vivo optical and µCT imaging to monitor infection, inflammation and bone anatomy in an orthopaedic implant infection in mice. Journal of Visualized Experiments (92), e51612. doi: 10.3791/51612.
Key words: inflammation, bone anatomy, orthopaedic implant
http://www.jove.com/video/51612/combined-vivo-optical-ct-imaging-to-monitor-infection-inflammation
PMID: 25350287

2. Crane GM, Xian RR, Burns KH, Borowitz MJ, Duffied AS, Taube JM. Primary effusion lymphoma presenting as a cutaneous intravascular lymphoma. J Cutan Pathol. 2014 Oct 30. doi: 10.1111/cup.12405.
Key words: Epstein-Barr virus (EBV); human herpesvirus type-8 (HHV-8); intravascular lymphoma; primary effusion lymphoma; skin biopsy
http://www.ncbi.nlm.nih.gov/pubmed/?term=25355615

3. Guss LJ, Ghazariain SR, Daya N, Okoye GA. Cutaneous sarcoidosis in African Americans. Austin J Dermatolog. 2014;1(6):4
Key words: cutaneous sarcoidosis, African Americans
http://austinpublishinggroup.org/dermatology/download.php?file=fulltext/ajd-v1-id1028.pdf
no PMID available

4. Llosa NJ, Cruise M, Tam A, Wick EC, Hechenbleikner EM, Taube JM, Blosser L, Fan H, Wang H, Luber B, Zhang M, Papadopoulos N, Kinzler KW, Vogelstein B, Sears CL, Anders RA, Pardoll DM, and Housseau F. The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. Cancer Discov. 2014 Oct 30. pii: CD-14-0863. [Epub ahead of print].
Key words: colon cancer, microsatellite
http://www.ncbi.nlm.nih.gov/pubmed/?term=25358689

5. Mathios D. Ruzevick J, Jackson C, Xu H, Taube JM, Burger P, and Lim M. PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment. J Neurooncol. 2014 Oct 28. [Epub ahead of print]
Key words: chordoma, microenvironment, immune system
http://www.ncbi.nlm.nih.gov/pubmed/?term=25349132

6. Rodic N, Anders RA, Eshleman JR, Lin MT, Xu H, Kim JH, Beirl K, Chen S, Luber BS, Wang H, Topalian SL, Pardoll DM, Taube JM. PD-L1 expression in melanocytic lesions does not correlate with the BRAF V600E mutation. Cancer Immunol Res. 2014 Nov 4. [Epub ahead of print].
Key words: melanoma, lesions, BRAF mutation
http://www.ncbi.nlm.nih.gov/pubmed/?term=25370533

1. Nelson GE, Neofytos D, Fischer M, Durand CM. A 70-year-old kidney transplant recipient presenting with persistent leg cellulitis. Clin Infect Dis. 2014 Sep 1;59(5):688,745-746.
Key words: cellulitis, kidney transplant
http://www.ncbi.nlm.nih.gov/pubmed/25116730

1. Agi C, Kuhn D, Chung J, Zampella J, Hinds G. Racial differences in the use of extracorporeal photopheresis for mycosis fungoides. J Dermatolog Treat. 2014 Jul 18:1-0.
Key words: ECP; cutaneous T-cell lymphoma; ethnic skin; mycosis fungoides
http://www.ncbi.nlm.nih.gov/pubmed/25034002

1. Püttgen KB. Diagnosis and management of infantile hemangiomas. Pediatr Clin North Am. 2014 Apr; 61(2):383-402.
Key words: Infantile hemangioma, PHACE syndrome, Propranolol, Timolol, ?-Blocker
http://www.ncbi.nlm.nih.gov/pubmed/?term=24636652

1. Olson MT, Harrington C, Beierl K, Chen G, Thiess M, O'Neill A, Taube J, Zeiger MA, Lin M, Eshleman JR. BRAF pyrosequencing analysis aided by a lookup table. Am J Clin Pathol. 2014 May; 141(5):639-47.
Key words: BRAF mutations, bioinformatics, pyromaker, pyrosequencing, pyrosequencing analysis
http://www.ncbi.nlm.nih.gov/pubmed/24713734

2. Malm IJ, Bruno TC, Fu J, Zeng Q, Taube JM, Westra W, Pardoll D, Drake CG, Kim YJ. Expression profile and in vitro blockade of PD-1 in HPV-negative head and neck squamous cell carcinoma. Head Neck 2014 Apr 7. [Epub ahead of print].
Key words: HNSCC, T cell, anergy, immunotherapy, programmed death 1 (PD-1)
http://www.ncbi.nlm.nih.gov/pubmed/24710745

3. Taube JM, Klein AP, Brahmer JR, Xu H, Pan X, Kim JH, Chen L, Pardoll DM, Topalian S, Anders RA. Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy. Clin Can Res. 2014 Apr 8. [Epub ahead of print].
Key words: PD-1, ligands, tumor suppression, nivolumab
http://www.ncbi.nlm.nih.gov/pubmed/24714771

1. Balagula Y1, Kang S, Patel MJ. Synergism between mTOR pathway and Ultraviolet radiation in the pathogenesis of squamous cell carcinoma and its implication for solid-organ transplant recipients. Photodermatol Photoimmunol Photomed. 2014 Feb 11. doi: 10.1111/phpp.12115. [Epub ahead of print]
Key words: NMSC, mammalian target of rapamycin, squamous cell carcinoma, transplant, ultraviolet radiation
http://www.ncbi.nlm.nih.gov/pubmed/24517835

2. Bauman NM, McCarter RJ, Guzzetta PC, Shin JJ, Oh AK, Preciado DA, He J, Greene EA, Puttgen KB.
Propranolol vs prednisolone for symptomatic proliferating infantile hemangiomas: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2014 Feb 13. doi: 10.1001/jamaoto.2013.6723. [Epub ahead of print]
Key words: hemangiomas, propranolol, prednisolone
http://www.ncbi.nlm.nih.gov/pubmed/24526257

3. Braunstein I, Gangadhar TC, Elenitsas R, Chu EY. Vemurafenib-induced interface dermatitis manifesting as radiation-recall and a keratosis pilaris-like eruption. J Cutan Pathol. 2014 Feb 12. doi: 10.1111/cup.12318. [Epub ahead of print]
Key words: dermatopathology, melanoma, radiation therapy
http://www.ncbi.nlm.nih.gov/pubmed/24517243

4. Crane GM, Ambinder RF, Shirley CM, Fishman EK, Kasamon YL, Taube JM, Borowitz MJ, Duffield AS. HHV-8-positive and EBV-positive Intravascular Lymphoma: an unusual presentation of extracavitary primary effusion lymphoma. Am J Surg Pathol. 2014 Mar;38(3):426-32.
Key words: extracavitary primary effusion lymphoma
http://www.ncbi.nlm.nih.gov/pubmed/24525514

5. Dudley JC, Gurda GT, Tseng LH, Anderson DA, Chen G, Taube JM, Gocke CD, Eshleman JR, Lin MT. Tumor cellularity as a quality assurance measure for accurate clinical detection of BRAF mutations in melanoma. Mol Diagn Ther. 2014 Mar 7. [Epub ahead of print]
Key words: quality assurance, BRAF mutation, melanoma
http://www.ncbi.nlm.nih.gov/pubmed/24604154

6. Elwood H, Kim J, Yemelyanova A, Ronnett BM, Taube JM. Basal cell carcinomas of the vulva: high-risk human papillomavirus DNA detection, p16 and BerEP4 expression. Am J Surg Pathol. 2014 Apr;38(4):542-7.
http://www.ncbi.nlm.nih.gov/pubmed/?term=24634379

7. Taube JM. Emerging immunologic biomarkers: setting the [TNM-immune] stage. Clin Cancer Res. 2014 Mar 14. [Epub ahead of print]
Key words: immunologic biomarkers
http://www.ncbi.nlm.nih.gov/pubmed/24634379

8. Tekes A, Koshy J, Kalayci TO, Puttgen K, Cohen B, Redett R, Mitchell SE. S.E. Mitchell Vascular Anomalies Flow Chart (SEMVAFC): A visual pathway combining clinical and imaging findings for classification of soft-tissue vascular anomalies. Clin Radiol. 2014 Feb 11. pii: S0009-9260(13)00551-5. doi: 10.1016/j.crad.2013.11.016. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/24529409

9. Topalian SL, Sznol M, McDermott DF, Kluger HM, Carvajal RD, Sharfman WH, Brahmer JR, Lawrence DP, Atkins MB, Powderly JD, Leming PD, Lipson EJ, Puzanov I, Smith DC, Taube JM, Wigginton JM, Kollia GD, Gupta A, Pardoll DM, Sosman JA, Hodi FS. Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab. J Clin Oncol. 2014 Mar 3. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/24590637

1. Crane GM, Ambinder RF, Shirley CM, Fishman EK, Kasamon YL, Taube JM, Borowitz MJ, and Duffield AS. HHV-8-positive and EBV-positive intravascular lymphoma: an unusual presentation of extracavity primary effusion lymphoma. Am J Surg Pathol. 2014 Mar;38(3):426-32.
http://www.ncbi.nlm.nih.gov/pubmed/24525514

2. Lazarus G, Valle MF, Malas M, Qazi U, Maruthur NM, Doggett D, Fawole OA, Bass EB, Zenilman J. Chronic venous leg ulcer treatment: Future Research Needs. Wound Repair Regen. 2014 Jan;22(1):34-42.
Key words: leg ulcer, treatment
http://www.ncbi.nlm.nih.gov/pubmed/24134795

3. Morison WL and Richard EG. Polymorphic light eruption. In: Treatment of Skin Disease, 4th edition. Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I. London: Saunders Elsevier.
No PMID available

4. Richard E, Hönigsmann H. Phototherapy in the age of biologics. Photodermatol Photoimmunol Photomed. 2014;30:3-7.
Key words: biologics, phototherapy, psoriasis
http://www.ncbi.nlm.nih.gov/pubmed/?term=24313462

5. Stavrakis, AI, Niska, JA, Shahbazian, JH, Loftin, AH, Ramos, RI, Billi, F, Francis, KP, Otto, M, Bernthal, NM, Uslan, DZ, Miller, LS. Combination Prophylactic Therapy with Rifampin has Increased Efficacy Against an Experimental Staphylococcus epidermidis Subcutaneous Implant-Related Infection. Antimicrob Agents Chemother. 2014. Feb 10. epub ahead of print.
http://www.ncbi.nlm.nih.gov/pubmed/24514089

1. Braunstein I, Wanat KA, Elenitsas R, Xu X, Frey N, Rosenbach M. Eltrombopag-associated hyperpigmentation. JAMA Dermatol. 2013 Sep;149(9):1112-5.
Key words: eltrombopag, hyperpigmentation
http://www.ncbi.nlm.nih.gov/pubmed/23884150

2. Granick JL, Falahee PC, Dahmubed D, Borjesson DL, Miller LS, Simon SI. Staphylococcus aureus recognition by hematopoietic stem and progenitor cells via TLR2/MyD88/PGE2 stimulates granulopoiesis in wounds. Blood. 2013 Sep 5;122(10):1770-8.
Key words: Staphylococcus auerus, stem cells, granulopoiesis
http://www.ncbi.nlm.nih.gov/pubmed/23869087

3. Hinds GA, Alhariri J, Klein RQ, Wilson LD. Treatment of mycosis fungoides with total skin electron beam: response and relapse by ethnicity and sex. Am J Clin Oncol. 2013 Oct;36(5):481-5.
Key words: mycosis fungoides, electron beam
http://www.ncbi.nlm.nih.gov/pubmed/22706179

4. Nakib S, Han J, Li T, Joshipura K, Qureshi AA. Periodontal disease and risk of psoriasis among nurses in the United States. Acta Odontol Scand. 2013 Nov;71(6):1423-9. doi: 10.3109/00016357.2013.766360.
Key words: periodontal disease, psoriasis, nurses
http://www.ncbi.nlm.nih.gov/pubmed/23374087

5. Niska JA, Shahbazian JH, Ramos RI, Francis KP, Bernthal NM, Miller LS. Vancomycin-rifampin combination therapy has enhanced efficacy against an experimental Staphylococcus aureus prosthetic joint infection. Antimicrob Agents Chemother. 2013 Oct;57(10):5080-6.
Key words: vancomycin-rifampin, Staphylococcus aureus, prosthetic joint infection
http://www.ncbi.nlm.nih.gov/pubmed/23917317

6. Puttgen KB, Summerer B, Schneider J, Cohen BA, Boss EF, Bauman NM. Cardiovascular and blood glucose parameters in infants during propranolol initiation for treatment of symptomatic infantile hemangiomas. Ann Otol Rhinol Laryngol. 2013 Sep;122(9):550-4.
Key words: blood glucose, propranolol, infantile hemangiomas
http://www.ncbi.nlm.nih.gov/pubmed/24224397

7. Rosenthal IM, Taube JM, Nelson DL, Erdag G. A case of infraorbital lichen sclerosus. Dermatol Online J. 2013 Oct 16;19(10):20021.
Key words: infraorbital lichen sclerosus, case study
http://www.ncbi.nlm.nih.gov/pubmed/24139364

8. Wrangle J, Wang W, Koch A, Easwaran H, Mohammad HP, Vendetti F, Vancriekinge W, Demeyer T, Du Z, Parsana P, Rodgers K, Yen RW, Zahnow CA, Taube JM, Brahmer JR, Tykodi SS, Easton K, Carvajal RD, Jones PA, Laird PW, Weisenberger DJ, Tsai S, Juergens RA, Topalian SL, Rudin CM, Brock MV, Pardoll D, Baylin SB. Alterations of immune response of non-small cell lung cancer with azacytidine. Oncotarget. 2013 Oct 25. [Epub ahead of print]
Key words: immune response, lung cancer, azacytidine
http://www.ncbi.nlm.nih.gov/pubmed/24162015

Return to top of Publications - Dermatology Archives


Search Publications
 
   
September 2016 articles:
Henrietta Lacks Memorial Lecture
Johns Hopkins Institute for Clinical and Translational Research
Johns Hopkins Research Network
JHM HSR Recertification Training
 
Visit Animal Care and Use Committee Website
Current Classes
"Interinstitutional Assurance" Agreement
Health, Safety, and Environment (HSE) presents: Safety in Research Updates
7th Annual Mirowski Discovery Award
Department of Defense Prostate Cancer Research Program (PCRP)
2016 Martin D. Abeloff Award for Excellence in Public Health and Cancer Control
The Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases Discovery Program
2017 Arnold O. Beckman Postdoctoral Fellowship for Life Sciences Research
Progeria Research Foundation Seeks Proposals for Research on Hutchinson-Gilford Progeria Syndrome (HGPS, or Progeria)
Burroughs Wellcome Fund - Career Awards for Medical Scientists
Bright Focus Foundation Alzheimer's Disease Research Grants
Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation Grant Program
Bright Focus Foundation National Glaucoma Research Grants
Milstein Medical Asian American Partnership Foundation Fellowship and Project Awards
Michael J. Fox Foundation (MJFF) Challenge
Research Administration Training Program for Existing Staff (RPES)
NIH Policy: Foreign Components Added to a Grant to a Domestic or Foreign Organization

This Month's Departmental Listings

Upcoming Deadlines for September, October and November

The JHU SOM Core Showcase
September Events at the Genetic Resources Core Facility
       

 

JHM AppointmentsEmployment @ JHM | Finding a Doctor | Disclaimer | Maps & Directions | Contact JHM 

 

                                                                                                                                                           The Web Center